STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Avant Technologies JV Partner to Speak at AI Revolution in Healthcare Summit in Dubai

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
partnership conferences AI

Avant Technologies (OTCQB:AVAI) announced that Vinicio Vargas, CEO of their joint venture partner Ainnova Tech and board member of Ai-nova Acquisition Corp (AAC), will be a featured speaker at the 2025 AI Revolution in Healthcare Summit in Dubai on February 15-16.

Vargas will address experts and investors about the clinical adoption of AI in healthcare, focusing on how it improves diagnostics and expands access to underserved communities. His presentation will cover key adoption drivers like investments in telemedicine and AI-powered imaging, while discussing challenges in data standardization, regulatory compliance, and workforce training.

As a panelist, he will participate in discussions about ethics in healthcare AI deployment, including data privacy, algorithmic bias, transparency in AI decision-making, and regulatory compliance across regions.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

LAS VEGAS, NEVADA / ACCESS Newswire / February 13, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Vinicio Vargas, the co-founder and Chief Executive Officer of Ainnova and member of the board of directors for Ai-nova Acquisition Corp. (AAC), a joint venture formed by both companies, will be a highlighted speaker at the 2025 AI Revolution in Healthcare Summit in Dubai, UAE, on February 15-16.

Vargas, who is spearheading the success of AAC in the AI healthcare industry, will speak to an audience of experts and investors in AI on the clinical adoption of AI and how it is transforming healthcare, improving diagnostics, and expanding access to underserved communities. He will introduce the key drivers of AI adoption, including growing investments in telemedicine and AI-powered imaging, discuss the challenges that remain in data standardization, regulatory compliance, and workforce training, and speak to the importance of collaboration among governments, providers, and tech leaders, which he says is vital for equitable AI integration.

While attending the Summit, Vargas will offer his expertise in the industry as a panelist. He will make up a panel of experts that will explore a range of topics on the ethics in deploying AI in healthcare settings, including:

  • Data Privacy and Security: Ensuring patient confidentiality and safeguarding sensitive information in AI applications.

  • Bias and Fairness: Addressing potential biases in AI algorithms to promote equitable healthcare outcomes.

  • Transparency and Accountability: Maintaining clarity in AI decision-making processes and establishing responsibility for AI-driven outcomes.

  • Regulatory Compliance: Navigating the legal frameworks governing AI deployment in healthcare across different regions.

To learn more about the 2025 AI Revolution in Healthcare Summit in Dubai, visit: https://events.assimilate.one/AI-Revolution-in-Healthcare-Dubai-2025#/?lang=en

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce VisionAI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Avant Technologies, Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI https://www.linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the

Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies, Inc.
info@avanttechnologies.com

SOURCE: Avant Technologies



View the original press release on ACCESS Newswire

FAQ

What will Vinicio Vargas discuss at the 2025 AI Revolution in Healthcare Summit in Dubai?

Vinicio Vargas will discuss clinical adoption of AI in healthcare, focusing on improving diagnostics, expanding access to underserved communities, telemedicine investments, AI-powered imaging, and challenges in data standardization and regulatory compliance.

What ethical topics will be covered in the AI healthcare panel featuring AVAI's joint venture partner?

The panel will cover data privacy and security, bias and fairness in AI algorithms, transparency in AI decision-making, and regulatory compliance across different regions.

When and where is Avant Technologies' (AVAI) joint venture partner speaking at the AI Healthcare Summit?

The speaking engagement is scheduled for February 15-16, 2025, at the AI Revolution in Healthcare Summit in Dubai, UAE.

What is the relationship between Avant Technologies (AVAI) and Ainnova Tech?

Avant Technologies and Ainnova Tech are partners who have formed a joint venture called Ai-nova Acquisition Corp (AAC), with Ainnova's CEO Vinicio Vargas serving on AAC's board of directors.
Avant Technologies Inc

OTC:AVAI

AVAI Rankings

AVAI Latest News

AVAI Latest SEC Filings

AVAI Stock Data

57.80M
108.49M
21.46%
Software - Application
Technology
Link
Lithuania
Vilnius